Peri-implant Soft Tissue Phenotype and Early Marginal Bone Loss After Dental Implant Placement
Impact of Peri-implant Soft Tissue Phenotype on Early Marginal Bone Loss: A Prospective Cohort Study
1 other identifier
observational
39
1 country
1
Brief Summary
This prospective observational cohort study evaluated the relationship between peri-implant soft tissue characteristics and early marginal bone loss following dental implant placement. The study included patients receiving bone-level implants in posterior edentulous regions. Keratinized mucosa width, supracrestal tissue height, and mucosal thickness were measured at the time of implant placement. Marginal bone levels were assessed using standardized intraoral radiographs obtained at baseline and three months after implant placement. The primary aim was to determine whether these peri-implant soft tissue dimensions were associated with marginal bone loss during the early healing period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
August 12, 2026
CompletedFirst Posted
Study publicly available on registry
August 17, 2026
CompletedAugust 17, 2026
August 1, 2026
2.4 years
August 12, 2026
August 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Marginal Bone Loss Around Dental Implants
Marginal bone loss was determined from standardized intraoral periapical radiographs obtained at implant placement (baseline) and at the three-month follow-up. Marginal bone level was measured on the mesial and distal aspects of each implant as the distance from the implant platform to the first bone-to-implant contact. Measurements were calibrated using the known implant length. Marginal bone loss was calculated as the change in marginal bone level from baseline to three months, and the mean of the mesial and distal measurements was used for analysis. Higher values indicate greater marginal bone loss.
Baseline to 3 months after implant placement
Study Arms (1)
Patients Receiving Dental Implants
A single prospective cohort of patients receiving bone-level dental implants in posterior edentulous regions. Peri-implant soft tissue dimensions, including keratinized mucosa width, supracrestal tissue height, and mucosal thickness, were measured at implant placement. Participants were not assigned to groups based on these measurements; soft tissue dimensions were evaluated as observational exposure variables in relation to marginal bone changes during the three-month follow-up.
Eligibility Criteria
Patients presenting to the Department of Periodontology, Faculty of Dentistry, Ankara University, for implant-supported rehabilitation of posterior edentulous regions were considered for participation in this prospective cohort study. Eligible patients who underwent bone-level dental implant placement and agreed to participate were prospectively enrolled.
You may qualify if:
- Age between 20 and 60 years. Good general health. Need for dental implant treatment in a posterior edentulous region. Adequate native bone volume for implant placement without bone augmentation. At least 3 months since tooth extraction at the planned implant site. Presence of stable opposing teeth. Adequate oral hygiene. Ability to attend follow-up visits
You may not qualify if:
- Heavy smoking. Uncontrolled systemic disease. Pregnancy. Use of antibiotics or anti-inflammatory medications within the previous 3 months.
- Bruxism. Poor oral hygiene. Need for bone augmentation at the implant site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara University Faculty of Dentistry
Ankara, Ankara, 06560, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst Prof Dr
Study Record Dates
First Submitted
August 12, 2026
First Posted
August 17, 2026
Study Start
August 8, 2023
Primary Completion
January 15, 2026
Study Completion
January 15, 2026
Last Updated
August 17, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly shared due to participant confidentiality and data protection considerations. Aggregated study findings will be reported in scientific publications.